ProShare Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Sell |
20,686
-951
| -4% | -$8.91K | ﹤0.01% | 1733 |
|
|
2025
Q1 | $266K | Sell |
21,637
-5,546
| -20% | -$68.1K | ﹤0.01% | 1491 |
|
|
2024
Q4 | $359K | Buy |
27,183
+6,627
| +32% | +$87.6K | ﹤0.01% | 1491 |
|
|
2024
Q3 | $396K | Sell |
20,556
-11,044
| -35% | -$213K | ﹤0.01% | 1282 |
|
|
2024
Q2 | $649K | Buy |
31,600
+11,488
| +57% | +$236K | ﹤0.01% | 860 |
|
|
2024
Q1 | $479K | Buy |
20,112
+4,599
| +30% | +$109K | ﹤0.01% | 1110 |
|
|
2023
Q4 | $335K | Buy |
15,513
+2,411
| +18% | +$52.1K | ﹤0.01% | 1295 |
|
|
2023
Q3 | $190K | Buy |
13,102
+80
| +0.6% | +$1.16K | ﹤0.01% | 1488 |
|
|
2023
Q2 | $273K | Buy |
13,022
+1,196
| +10% | +$25K | ﹤0.01% | 1331 |
|
|
2023
Q1 | $250K | Sell |
11,826
-1
| -0% | -$21 | ﹤0.01% | 1310 |
|
|
2022
Q4 | $301K | Buy |
11,827
+1,201
| +11% | +$30.6K | ﹤0.01% | 1233 |
|
|
2022
Q3 | $255K | Buy |
10,626
+433
| +4% | +$10.4K | ﹤0.01% | 1242 |
|
|
2022
Q2 | $195K | Sell |
10,193
-4,443
| -30% | -$85K | ﹤0.01% | 1482 |
|
|
2022
Q1 | $254K | Sell |
14,636
-2,149
| -13% | -$37.3K | ﹤0.01% | 1751 |
|
|
2021
Q4 | $367K | Buy |
16,785
+634
| +4% | +$13.9K | ﹤0.01% | 1667 |
|
|
2021
Q3 | $309K | Sell |
16,151
-4,183
| -21% | -$80K | ﹤0.01% | 1523 |
|
|
2021
Q2 | $349K | Buy |
20,334
+5,478
| +37% | +$94K | ﹤0.01% | 1787 |
|
|
2021
Q1 | $332K | Buy |
14,856
+2,581
| +21% | +$57.7K | ﹤0.01% | 1741 |
|
|
2020
Q4 | $273K | Buy |
+12,275
| New | +$273K | ﹤0.01% | 1671 |
|
|
2018
Q4 | – | Sell |
-11,240
| Closed | -$91K | – | 1689 |
|
|
2018
Q3 | $91K | Sell |
11,240
-1,097
| -9% | -$8.88K | ﹤0.01% | 1693 |
|
|
2018
Q2 | $87K | Sell |
12,337
-445
| -3% | -$3.14K | ﹤0.01% | 1724 |
|
|
2018
Q1 | $182K | Sell |
12,782
-2,105
| -14% | -$30K | ﹤0.01% | 1570 |
|
|
2017
Q4 | $130K | Buy |
+14,887
| New | +$130K | ﹤0.01% | 1712 |
|